-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On January 10, Sailong Pharmaceutical Group Co.
, Ltd.
announced that its wholly-owned subsidiary, Hunan Sailong Pharmaceutical Co.
, Ltd.
, has recently obtained the “Approval for Supplementary Drug Application for Milrinone Injection” approved and issued by the State Drug Administration.
Notice"
.
It is reported that the main indication of milrinone injection is for short-term intravenous treatment of patients with acute decompensated heart failure
.
It is worth mentioning that Theron Pharmaceuticals has changed the prescription process and storage conditions in the application content
Sialon Milrinone injection has passed the quality and efficacy consistency evaluation of generic drugs, and the new 10ml:10mg specification is conducive to optimizing the company's product structure, better meeting clinical drug needs, and further enhancing the product's market.